Next Article in Journal
Research Priorities for the Pan-Canadian Oncology Symptom Triage and Remote Support Practice Guides: A Modified Nominal Group Consensus
Previous Article in Journal
When the Oncologist Becomes the Patient
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 26
Issue 3
10.3747/co.26.4575
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Assessing the Impact of Mailing Self-Sampling Kits for Human Papillomavirus Testing to Unscreened Non-Responder Women in Manitoba

by
F. Jalili
1,
C. O’Conaill
1,
K. Templeton
1,
R. Lotocki
1,
G. Fischer
2,
L. Manning
2,
K. Cormier
2 and
K. Decker
3,4,*
1
CervixCheck, CancerCare Manitoba, MB, Canada
2
Diagnostic Services, Shared Health Manitoba, MB, Canada
3
Department of Community Health Sciences, University of Manitoba, MB, Canada
4
Research Institute in Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2019, 26(3), 167-172; https://doi.org/10.3747/co.26.4575
Submission received: 5 March 2019 / Revised: 8 April 2019 / Accepted: 9 May 2019 / Published: 1 June 2019

Abstract

Background: CervixCheck, Manitoba’s cervical cancer screening program, conducted a pilot study to assess whether screening participation could be improved in unscreened women by offering a mailed self-sampling kit for human papillomavirus (HPV) testing instead of a Pap test. Methods: In a prospective cohort study design, a sample of unscreened women (n = 1052) who had been sent an invitation letter from CervixCheck in the past but who did not respond were randomized to either an intervention group or a control group. The intervention group received a mailed HPV self-sampling kit; the control group received no additional communication. Returned HPV self-sampling swabs were analyzed by a provincial laboratory. After 6 months, screening participation in the two study groups was compared using a logistic regression model adjusted for age and area of residence (urban or rural). Secondary outcomes included HPV positivity, specimen inadequacy, compliance with follow-up, and time to colposcopy. Results: Screening participation was significantly higher in the intervention group than in the control group (n = 51, 9.6%, vs. n = 13, 2.5%; odds ratio: 4.7; 95% confidence interval: 2.56 to 8.77). Geographic area of residence (urban or rural) and age were not statistically significant. Conclusions: The study demonstrated that HPV self-sampling kits can enhance screening participation in unscreened non-responder women in the setting of an organized screening program. Next steps should include additional research to determine the best implementation strategy for HPV self-sampling in Manitoba.
Keywords: human papillomavirus; dna tests; cervical cancer; cancer screening human papillomavirus; dna tests; cervical cancer; cancer screening

Share and Cite

MDPI and ACS Style

Jalili, F.; O’Conaill, C.; Templeton, K.; Lotocki, R.; Fischer, G.; Manning, L.; Cormier, K.; Decker, K. Assessing the Impact of Mailing Self-Sampling Kits for Human Papillomavirus Testing to Unscreened Non-Responder Women in Manitoba. Curr. Oncol. 2019, 26, 167-172. https://doi.org/10.3747/co.26.4575

AMA Style

Jalili F, O’Conaill C, Templeton K, Lotocki R, Fischer G, Manning L, Cormier K, Decker K. Assessing the Impact of Mailing Self-Sampling Kits for Human Papillomavirus Testing to Unscreened Non-Responder Women in Manitoba. Current Oncology. 2019; 26(3):167-172. https://doi.org/10.3747/co.26.4575

Chicago/Turabian Style

Jalili, F., C. O’Conaill, K. Templeton, R. Lotocki, G. Fischer, L. Manning, K. Cormier, and K. Decker. 2019. "Assessing the Impact of Mailing Self-Sampling Kits for Human Papillomavirus Testing to Unscreened Non-Responder Women in Manitoba" Current Oncology 26, no. 3: 167-172. https://doi.org/10.3747/co.26.4575

APA Style

Jalili, F., O’Conaill, C., Templeton, K., Lotocki, R., Fischer, G., Manning, L., Cormier, K., & Decker, K. (2019). Assessing the Impact of Mailing Self-Sampling Kits for Human Papillomavirus Testing to Unscreened Non-Responder Women in Manitoba. Current Oncology, 26(3), 167-172. https://doi.org/10.3747/co.26.4575

Article Metrics

Back to TopTop